SciELO - Scientific Electronic Library Online

 
vol.28 issue4Anaerobio osteomyelitis. A rare condition in children author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Revista Colombiana de Reumatología

Print version ISSN 0121-8123

Rev.Colomb.Reumatol. vol.28 no.4 Bogotá Oct./Dec. 2021  Epub Dec 01, 2022

https://doi.org/10.1016/j.rcreue.2020.05.013 

Letter to the Editor

Validity induction: Comments on the study of Compliance Questionnaire for Rheumatology*

César Merino-Sotoa  ** 

Marisol Angulo-Ramosb 

a Psychology Research Institute, School of Psychology University of San Martín de Porres, Lima, Perú

b Research Institute, Catolic University Los Ángeles de Chimbote, Trujillo, Perú


Mr. Editor:

In a recent report,1 the validation and calibration of the Com pliance Questionnaire on Rheumatology (CQR), (2 one of the measures internationally valued as a "gold standard" and, possibly representative in the assessment of adherence3 is informed. The importance of the study of the authors is far from being questioned, but there are several methodological inaccuracies that could invalidate the study. This letter is intended to highlight these limitations.

The authors identify their work as one of validity, but it seems to be an unjustifiable ambitious nomination for the study conducted by them, because the investigation of the metric validity corresponds to a set of evidence,4 other than to a single one. This is due to the fact that the authors make a contribution aimed to the classificatory use of the scoring instruments and solve only one type of evidence. On the other hand, there is other unresolved evidence, and due to this it cannot be stated that there is no guarantee that the set of CQR items will function as an interpretable unit. Indeed, one of the fundamental validity evidences and that conditions other validity evidences is the internal structure4; this corresponds to determining the dimensionality and the parameters of the item-test relationship, the invariance of the metric properties and the reliability.4 Among these criteria, the first is the sine qua non evidence.

The problem is highlighted as a seriously problematic methodological issue for two reasons: first, the dimensionality of the CQR has not been usually investigated4 with recommended methods, even by the creators of the CQR them-selves, (2,6 and second, because in one of the few studies that analyzed the internal structure with multivariate methods,7 it was found that all the CQR items did not represent a single domain of measurement. Therefore, the results of Hughes7) suggest that it is reasonable to suppose that the dimensionality can be challenged and it must be investigated.

The absence of verification of the internal structure in the sample of study itself, and the citation of external sources of validity evidences instead of using the data themselves, are actions that characterize the induction of validity, ( 8 that is, when the statement of validity of an instrument is supported by the referencing of other studies with little or no relevance.

We conclude that a) the careful study of the diagnostic validity of the CQR4 should be accompanied by an evaluation of its dimensionality, and b) that the statement of validity of the CQR should be properly focused on the specific type of evidence evaluated.

references

1. Fernández-Ávila D, Accini M, Tobón M, Moreno S, Rodríguez V, Gutiérrez J. Validation and calibration to Spanish of the Compliance Questionnaire on Rheumatology in a group of Colombian patients on treatment for rheumatoid arthritis. Rev Colomb Reumatol. 2019;26:105-10, http://dx.doi.org/10.1016/j.rcreu.2019.03.001. [ Links ]

2. de Klerk E, van der Heijde D, van der Tempel H, van der Linden S. Development of a questionnaire to investigate patient compliance with antirheumatic drug therapy. J Rheumatol. 1999;26:2635-41. [ Links ]

3. Rincón J, Jaimes D, García J, Beltrán A, Téllez A, Fernández-Ávila DG, et al. Methods for measuring adherence to oral disease-modifying drugs in rheumatoid arthritis and factors associated with low adherence to pharmacological treatment. Rev Colomb Reumatol. 2018;25:261-70, http://dx.doi.org/10.1016/j.rcreu.2018.07.002. [ Links ]

4. Boateng GO, Neilands TB, Frongillo EA, Melgar-Quiñonez HR, Young SL. Best practices for developing and validating scales for health, social, and behavioral research: a primer. Front Public Health. 2018;6:149, http://dx.doi.org/10.3389/fpubh.2018.00149. [ Links ]

5. Lewis TF. Evidence regarding the internal structure: confirmatory factor analysis. Meas Eval Couns Dev. 2017;50:239-47, http://dx.doi.org/10.1080/07481756.2017.1336929. [ Links ]

6. de Klerk E, van der Heijde D, Landewe R, van der Tempel H, van der Linden S. The compliance-questionnaire-rheumatology compared with electronic medication event monitoring: a validation study. J Rheumatol. 2003;30:2469-75. [ Links ]

7. Hughes LD, Done J, Young A. A 5 item version of the Compliance Questionnaire for Rheumatology (CQR5) successfully identifies low adherence to DMARDs. BMC Musculoskelet Disord. 2013;14:286. Available from: http://www.biomedcentral.com/1471-2474/14/286. [ Links ]

8. Merino-Soto C, Calderón-De la Cruz GA. Validez de estudios peruanos sobre estrés y burnout. Rev Perú Med Exp Salud Publica. 2018;35:353-4, http://dx.doi.org/10.17843/rpmesp.2018.352.3521. [ Links ]

* Please cite this article as: Merino-Soto C, Angulo-Ramos M. Inducción de la validez: comentarios al estudio de validación del Compli ance Questionnaire on Rheumatology. Rev Colomb Reumatol. 2021;28:312-313.

PII of original article: S0121-8123(20)30056-6

**Corresponding author. E-mail address: sikayax@yahoo.com.ar (C. Merino-Soto). 2444-4405/

Creative Commons License This is an open-access article distributed under the terms of the Creative Commons Attribution License